International Brachytherapy (IBt), a subsidiary of radiotherapy and radiopharmaceutical developer Eckert & Ziegler of Berlin, has set up a joint venture with Russian state fund Rusnanotech and local partners to manufacture prostate cancer implants in that country, Eckert & Ziegler said.
The joint venture, which will be based in Moscow, plans to invest up to 23.2 million euros (approximately $30 million) within the next five years in acquiring manufacturing licenses, building a production facility, and expanding a distribution network, according to Eckert & Ziegler.
Related Reading
Eckert & Ziegler acquires Nuclitec, January 26, 2009
Eckert & Ziegler, IBt consolidate brachytherapy units, February 19, 2008
Eckert & Ziegler launch new gallium generator, November 13, 2007
Eckert & Ziegler ends deal with RadQual, March 15, 2007
Eckert & Ziegler notch Venezuelan order, January 4, 2007
Copyright © 2009 AuntMinnie.com
